DELBio

DELBio is a Taiwanese biotechnology company associated with Delta Electronics. It was established in May 2010 as a dedicated vehicle for the group's biomedical activities, receiving Delta Electronics' existing biomedical products and research-and-development platforms. The company's formation followed several years of investment by Delta in biomedical products and related R&D, beginning in 2005. DELBio's business scope is described in the available reference material at a high level rather than through a detailed public product catalogue. Its role has included biomedical product development, ownership or continuation of biomedical R&D platforms transferred from Delta Electronics, and original-equipment manufacturing activity. The company has been identified as an OEM for Omron, indicating participation in business-to-business supply and manufacturing arrangements in the medical or health-technology sector. A reported regulatory milestone came in 2010, when DELBio obtained United States Food and Drug Administration 510(k) clearance. The available material does not identify the cleared device, its indication, or the exact clearance number, so those details cannot be stated reliably here. The clearance nevertheless indicates that the company was pursuing regulated medical-device commercialization rather than operating solely as a research organization. Publicly available information about DELBio is limited. The supplied references do not establish a current executive roster, a standalone website, a detailed geographic footprint, financial results, ownership changes, or the company's present operating status. Accordingly, this entry treats DELBio as a Delta Electronics-affiliated Taiwanese biotechnology and biomedical-products company while leaving current corporate facts open for verification.

DELBio's documented history begins with Delta Electronics' investment in biomedical activities. From 2005 onward, Delta is reported to have committed resources to biomedical products and associated research and development. This earlier investment created the technical and product base that was later transferred to a dedicated subsidiary or affiliated operating entity. In May 2010, DELBio Inc. was founded as a biotechnology company belonging to Delta Electronics. At its creation, the company received Delta Electronics Group's existing biomedical products and R&D platforms. The transfer gave DELBio a defined operating foundation rather than requiring it to build its biomedical portfolio entirely from the beginning. The available account does not specify the individual platforms, laboratories, personnel, or product names involved in the transfer. Also in 2010, DELBio reportedly obtained approval through the United States Food and Drug Administration's 510(k) pathway. A 510(k) submission is generally used to demonstrate that a medical device is substantially equivalent to a legally marketed predicate device. However, the supplied reference does not identify the specific DELBio product, its medical indication, the predicate device, or the clearance reference number. The regulatory event should therefore be recorded as a company milestone without attributing it to a particular product. DELBio has also been described as an original-equipment manufacturer for Omron. This suggests that part of its commercial activity involved producing or supplying biomedical or medical-device products for another established healthcare brand. The references do not provide the scope, duration, geography, or product categories of the Omron relationship. Beyond these early milestones, the available Wikipedia material contains little verified information about DELBio's subsequent product launches, corporate structure, leadership, financial performance, market expansion, or current status. No documented scandals, lawsuits, acquisitions, major campaigns, or leadership changes are identified in the supplied sources. Its historical profile is therefore best understood as that of a Delta Electronics-affiliated Taiwanese biomedical venture created to consolidate and commercialize the group's prior biomedical technology work.

1. 2010DELBio is founded

   DELBio Inc. is established in May as a Delta Electronics-affiliated biotechnology company and receives existing biomedical products and R&D platforms from the Delta Electronics Group.

   Source
2. 2010FDA 510(k) clearance

   DELBio is reported to have received United States FDA 510(k) approval or clearance. The available source does not specify the device or clearance number.

   Source
3. 2005Delta begins sustained biomedical investment

   Delta Electronics is reported to have begun investing resources in biomedical products and related research and development, creating the foundation for the later DELBio business.

   Source

Biotechnology and biomedical product development within the Delta Electronics Group, with a focus on regulated medical technologies and OEM manufacturing.

• Biomedical productsBiomedical technology

  DELBio inherited biomedical products developed within Delta Electronics Group. The available reference material does not name the individual products or describe their clinical applications, so this category is recorded at the portfolio level.

• Biomedical R&D platformsResearch and development platform2010

  At its formation, DELBio received existing biomedical research and development platforms from Delta Electronics Group. These platforms formed part of the technical base for the company's biotechnology and medical-product activities, although the source does not identify their technologies or operating sites.

• OEM biomedical productsOEM medical technology

  DELBio has been described as an OEM for Omron, indicating that it manufactured or supplied biomedical products for an external healthcare brand. The available source does not identify the specific products, contractual period, or markets involved.

1. DELBio